SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

FULC

Fulcrum Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 10h ago SEC0001104659-26-127211
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a Schedule 13D, which would signal activist intent. For now, the passive filing suggests no immediate change in strategy.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nantahala Capital Management disclosed a passive 8.62% stake in Fulcrum Therapeutics as of September 30, 2026, up from a prior filing where it reported zero shares. The increase is a routine update for a passive investment adviser and does not signal activist intent.

Key Financial Metrics

Stake
8.62%
Investor
Nantahala Capital Management, LLC
Investor Type
hedge fund

Key Facts

  • Nantahala Capital Management reported beneficial ownership of 6,575,352 shares (8.62%) of Fulcrum Therapeutics as of September 30, 2026.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent.
  • The stake increased from zero shares in a prior filing to 6,575,352 shares.
  • Wilmot B. Harkey and Daniel Mack are also named as reporting persons with the same 8.62% beneficial ownership.

Financial Impact

Stake valued at approximately $24.7M based on $286M market cap and 8.62% ownership.

ownership_percentage

Risk Factors

  • Passive holder could sell shares, creating downward pressure.
  • No indication of activist engagement; filing is routine.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001104659-26-127211
Document: 0001104659-26-127211-index.html0001104659-26-127211
Document: 0001104659-26-127211.txt0001104659-26-127211

Track record

23 reports on FULC

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +7.71% at T+60 after the Jul 15, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $3.72 Now $3.71 −0.27% settles Nov 18
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $3.73 Now $3.71 −0.40% settles Nov 17
  3. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $3.77 Now $3.71 −1.59% settles Nov 17
  4. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $3.77 Now $3.71 −1.59% settles Nov 17
  5. Nov 12, 20264d ago 425 Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
  6. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
  7. Nov 5, 202612d ago EFFECT Neutral 4/10 Entry $3.68 to $3.70 Now $3.71 +0.82% ▲ +0.54% +0.23% vs SPY
  8. Nov 3, 202613d ago S-4/A Neutral 5/10 Entry $3.74 to $3.77 Now $3.71 −0.80% ▲ +0.80% −0.85% vs SPY
  9. Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
  10. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 5h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026